tranScrip is a leading contract drug development organisation which supports pharma and biotech companies in the development and lifecycle of medicines.

We bring innovative solutions to clients’ global drug development needs. From translational medicine through to registration and post licencing, we deliver both strategic leadership and operational execution of development programmes, covering clinical, regulatory, drug safety, and commercial elements.

Our teams of physicians, scientists and regulatory experts, help clients select the most promising drug candidates and bring them to the market. We guide our clients through their decision making from first in man studies to proof of concept and pivotal trials, regulatory submissions and product launches. 

In the last decade, tranScrip has supported over 250 clients and has been integral to many development programmes and regulatory submissions, bringing products to the market each year across a wide range of therapeutic areas.

Pharmaceutical

Life Sciences

tranScrip

Mark Corbett

Gareth Dyson

Leon Joshi

Gabriel Vital-Durand

Linda Summerton

Karen Real

Karen Nugent

Stacey Godfrey

The Leadership Team at tranScrip is responsible for setting the strategic direction and operational oversight of the organization. Comprising experts in finance, clinical development, project delivery, and regulatory affairs, they collaborate to ensure successful drug development and commercialization for clients. This team drives innovative solutions, supports decision-making throughout the drug lifecycle, and fosters a culture of excellence while guiding cross-functional teams to meet the diverse needs of pharma and biotech partners.

Leadership Team

Clinical and Medical Operations

Regulatory Affairs Team

Leadership Team

About

Team members

Other teams at tranScrip

Clinical and Medical Operations

Regulatory Affairs Team